Oncology Research and Treatment

Article	Citations
PharmaNews	25
Polypharmazie - Wechselwirkungen der BTKi	24
uGI: Biomaker-Cut-Offs in der Immunonkologie	23
Front & Back Matter	21
Front & Back Matter	20
PharmaNews	18
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023	18
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience	17
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study	14
Society Bulletins	13
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice	13
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient selection and surgical management in advanced ovarian cancer: what tools do we have to make the right decision?	13
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis	12
Career and Professional Development for Young Oncologists	12
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors	12
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial	11
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease	10
Society Bulletins	9
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center	9
Front & Back Matter	7
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis	7
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 75	7
PharmaNews	7
Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy	7
OnkoImmun 21	7

Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem	7
PharmaNews	6
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine	6
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany	6
Sustained clinical response to Olaparib in a patient with metastatic pancreatic cancer and somatic ATM-Mutation R2034Ter: a case report	6
Front & Back Matter	5
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz	5
Evaluating the benefits and challenges of using patient preferences as a tool for clinical decision making in oncology MDT meetings within the National Health Service (NHS): A qualitative study	5
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer	5
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors	5
Routine Cancer Treatment Regimens and Its Impact on Fine Motor Dexterity in Breast Cancer	5
DKK 2024: Acalabrutinib im Praxis-Check	5
Vorwort des DGHO-Vorstands	4
Therapiemanagement von Sacituzumab Govitecan	4
Prelims	4
Epcoritamab: Indikationserweiterung für das FL	4
Society Bulletins	4
PharmaNews	4
PharmaNews	4
Tumor Infiltrating Lymphocytes, CAR-, and T Cell Receptor- Modified T Cells in Solid Cancer Oncology	4
Front & Back Matter	4
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients	4
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial	4
NSCLC: RWE-Daten zur Sequenztherapie	4
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer	4
PharmaNews	4
PharmaNews	4
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer	3
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report	3
Oncology in Europe	3
Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein	3
Risk and Prognosis of Subsequent Primary Gastric Cancer	3
Safety and efficacy of pharmacotherapy containing the second-generation INSTIs and chemotherapy drugs in AIDS-related diffuse large B-cell lymphoma: a single-center retrospective analysis	3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie	3
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL	3
Erratum	3
Durvalumab auch bei Hirnmetastasen vorteilhaft	3
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation	3
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac	3
Das inoperable NSCLC im Stadium III im Dialog	3
Society Bulletins	3
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality	3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%	3
Perspectives for Cancer Care and Research in Central and Eastern Europe	3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM	3
Recent Advances in Castleman Disease	2
Society Bulletins	2
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study	2
Modifications to prostate cancer diagnosis following COVID-19 and following models	2
PharmaNews	2

35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin	2
Society Bulletins	2
Society Bulletins	2
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries using GPT-4o Enhanced with German Evidence-Based Guidelines	2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie	2
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen	2
PharmaNews	2
Society Bulletins	2
Front & Back Matter	2
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich	2
Management of Patients Undergoing CAR-T Cell Therapy in Germany	2
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment	2
OnkoImmun 19	2
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review	2
Nivolumab plus Ipilimumab beim metastasierten Melanom	1
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	1
Society Bulletins	1
PharmaNews	1
PharmaNews	1
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis	1
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma	1
Contents Vol. 47, 2024	1
Nintedanib und Docetaxel beim Adenokarzinom der Lunge	1
Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care: A Randomized Pilot Study	1
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study	1
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy	1
OnkoImmun 18	1
Front & Back Matter	1
Society Bulletins	1
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database	1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis	1
Front & Back Matter	1
Prelims	1
Erweiterte Therapieoptionen bei EGFRm NSCLC	1
Front & Back Matter	1
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis	1
A Randomized, Controlled Pilot Study to Evaluate the Immediate Effect of Targeted Exercise Therapy on Cancer-Related Fatigue in Cancer Survivors: The FatiGO Study	1
PharmaNews	1
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers	1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study	1
Front & Back Matter	1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review	1
Prognostic Significance of HER2 Positivity in Endometrium Cancer	1
Acknowledgement to Reviewers	1
PharmaNews	1
Prelims	1
Chemoimmuntherapie als ein Standard bei ED-SCLC	0
EGFR plus MET Targeted Therapies for Overcoming Treatment Resistance in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Report	0
Prelims	0
Molecular tissue profiling in a clinically selected pancreatic cancer cohort	0
Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report	0
The Diagnostic Utility of cfDNA and ctDNA in Liquid Biopsies for Gastrointestinal Cancers over the Last Decade	0
PharmaNews	0
Radiofrequency Thermoablation and Hypofractionated Radiotherapy Combined Treatment for Bone Metastases: A Retrospective Study	0
Male Breast Cancer: Therapy-Induced Toxicities, Psychological Distress, and Individual Patient Goals during Oncological Inpatient Rehabilitation	0
Transparency on Platelet Transfusion in Routine Cancer Care: The Key for Optimal Blood Usage?	0
Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action	0
A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong	0
Incidence, Prevalence, and Real-World Treatment Patterns in Chronic Myeloid Leukemia: Results from a Population-Representative German Claims Data Analysis	0
Society Bulletins	0
Front & Back Matter	0
Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of Physicians	0
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors – Results from the PROSa Study	0
First-in-Class-Therapie mit Sacituzumab Govitecan	0
PharmaNews	0
Erstlinientherapie nicht-transplantationsfähiger Myelom-Patient*innen mit D-Rd	0
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience	0
Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?	0
Ibrutinib: signifikanter OS-Vorteil gegenüber FCR	0
New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas	0
PharmaNews	0
Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review	0
Society Bulletins	0
Society Bulletins	0
mNSCLC - Leitlinie empfiehlt POSEIDON-Regime	0
Vorwort des DGHO-Vorstandes	0
Inflammatory Myofibroblastic Tumor in the Thyroid Gland: A Retrospective Case Series Study and Literature Review	0
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany	0
Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatin	0
Navigating Gynecological Oncology with Different Versions of ChatGPT: A Transformative Breakthrough or the Next Black Box Challenge?	0

CTCL-Therapie mit Mogamulizumab	0
PharmaNews	0
Treatment of Metastatic Colorectal Carcinoma with Bevacizumab in First-Line and beyond First Progression: The KORALLE Non-Interventional Cohort Study	0
PharmaNews	0
PharmaNews	0
Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database	0
Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center	0
Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie	0
The Study of Cerebral Blood Flow Variations during Brain Metastases Radiotherapy	0
Associations of Dietary Factors with Cutaneous Melanoma: A Case-Control Study in Greece with Literature Review	0
Before-and-after Studies in Oncology: How Real Is the Real-World Evidence?	0
PARANEOPLASTIC PAPILLITIS AS A PRECURSOR TO COLON CARCINOMA. A CASE OF UNEXPECTED VISION LOSS LEADING TO EARLY CANCER DETECTION	0
Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients	0
Melflufen: Therapieoptionen beim Multiplen Myelom	0
Five-Fraction Stereotactic Radiotherapy for Brain Metastases: A Single-Institution Experience on Different Dose Schedules	0
Gender as a Contextual Factor in Quality of Life of Cancer Survivors: A Literature Review	0
Fortgeschrittenes oder nicht resezierbares HCC: explorative 4-Jahres-Analyse STRIDE	0
Preliminary Clinical Validation of a Filtration-Based CTC Assay for Tumor Burden and HER2 Status Monitoring in Metastatic Breast Cancer	0
AGSMO Jahreskongress 2023 - Abstracts	0
Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced Non-Small-Cell Lung Cancer Patients with Chronic Infection	0
Durable Responses to Chemotherapy in Patients with Metastatic Soft-Tissue Sarcoma	0
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany	0
Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy	0
Chancen tumoragnostischer Therapieansätze	0
The effect of PET CT parameters on pathological response in patients with HER-2 positive breast cancer receiving neoadjuvant treatment	0
Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group	0
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma	0
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis	0
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial	0
Neu bei mCRPC: Talazoparib + Enzalutamid	0
Vorteile des MAIA-Regimes bei Hochrisikozytogenetik	0
Society Bulletins	0
BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review	0
Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases	0
A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model	0
Palbociclib in Combination with either Aromatase Inhibitors or Fulvestrant for Patients with Advanced HR+/HER2− Breast Cancer in Germany: Final Results of the Phase 2 Multicohort INGE-B Trial	0
PharmaNews	0
PharmaNews	0
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas	0
PharmaNews	0
PharmaNews	0
Society Bulletins	0
Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom	0
Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study	0
Front & Back Matter	0
Prelims	0
Society Bulletins	0
The Burden of Fear of Cancer Recurrence in Genitourinary Cancers: A Prospective Study (NCT04535921)	0
Evaluating the Impact of Age and G8 Assessment on Definitive Treatment Strategies in Elderly Patients with Local Advanced Esophageal Carcinoma	0
Treatment satisfaction and treatment wishes of patients with chronic cancer-related pain	0
Erstmals 3-Jahres-Daten bei biliären Karzinomen	0
PharmaNews	0
Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement	0
BTKi: die Entwicklung geht weiter	0
Atezolizumab beim operablen NSCLC	0
Osimertinib: Hohe Wirksamkeit im Zentralnervensystem	0
Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort	0
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case	0
Front & Back Matter	0
PharmaNews	0
Momelotinib bei Myelofibrose und Anämie	0
Family Formation and Socio-Economic Status among 35-Year-Old Men Who Have Survived Cancer in Childhood and Early Adulthood: A Register-Based Cohort Study	0
Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer:	0
The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial	0
PharmaNews	0
Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort Study	0
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers	0
A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors	0
Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells	0
Updated International Guidelines for Survivorship Care after Pediatric Cancer: Practice Implications in a German and Austrian Comprehensive Care Network	0
PharmaNews	0
4-Jahres-Daten der CheckMate-9LA-Studie zum NSCLC	0
Zulassungserweiterung Yescarta beim r/r FL	0
Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and Survival Prognosis	0
Differential Expression of Immune Checkpoints TIM-3, LAG3, TIGIT, and Siglec-7 on Circulating NK Cells: Insights from Healthy Donors compared to Gastric Cancer Patients	0
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation	0
Society Bulletins	0
Prelims	0
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	0
Front & Back Matter	0
A Systematic Review for Evaluation of Specialized Programs for Addressing Young Women with Breast Cancer Problems	0
Society Bulletins	0
Society Bulletins	0
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer	0
Abemaciclib beim eBC und mBC	0
Resektabilität bei NSCLC III: Schlüssel zur Therapie	0
Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review	0
Stereotactic Radiotherapy for Penile Metastasis: Case Report and Systematic Literature Review	0
Prelims	0
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review	0
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome	0
Anaemia in Hospitalized Cancer Patients: A Retrospective Study of Two Cohorts before and after the Guideline Update	0
Front & Back Matter	0
Highlights from ESMO 2024 as a young head and neck oncologist	0
Effektive Therapieoption: Pegcetacoplan bei PNH	0